On June 18, 2025, Rocket Pharmaceuticals held its Annual Meeting where stockholders elected ten directors and ratified EisnerAmper LLP as the independent accounting firm for 2025, receiving 90,696,301 votes in favor. They also approved the compensation for named executives with 77,186,221 votes for the advisory resolution.